84 results on '"Sunanda V. Kane"'
Search Results
2. S763 A Cohort Study of the Age of Menopause in Female Patients With and Without Inflammatory Bowel Disease
3. S793 Real World Experience With Off-Label Upadacitinib in Crohn’s Disease at a Tertiary Care Center
4. S1930 Crohn’s Disease in a Patient With Fibrodysplasia Ossificans Progressiva
5. Does Size Really Matter?
6. S0886 Pregnancy Complications in Women With Inflammatory Bowel Disease: Results From the National Inpatient Sample
7. 761 Increased Risk of Preeclampsia in Women With Inflammatory Bowel Disease on Anti-TNF Therapy
8. 2757 Gastric Amyloid: The Patient Who Could Not Eat at AL
9. S1274 A National Survey of Burnout Among Gastroenterology Fellows in the United States
10. The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium
11. 1556 IBD Mimicker: Vascular Ehlers-Danlos Presenting as Spontaneous Bowel Perforation
12. 871 Impact of Patient Screening Process on Diagnostic and Therapeutic Yield of Double Balloon Enteroscopy
13. Trick or TREAT? More Safety Data of Infliximab During Pregnancy
14. Shifts in Vedolizumab Utilization Across the United States Are Associated With Improved Outcomes
15. Real World Usage Patterns of Vedolizumab in Inflammatory Bowel Disease: Results From the VICTORY Consortium: 2017 Presidential Poster Award
16. Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
17. Anti-TNF Exposure in Utero, What About My Twins?
18. Once-Daily Dosing vs. Conventional Dosing Schedule of Mesalamine and Relapse of Quiescent Ulcerative Colitis: Systematic Review and Meta-Analysis
19. An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
20. Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis
21. A Decrease in Hesitancy Towards Treatment with Adalimumab in Patients Enrolled in a Nurse Care Management Program
22. Adalimumab Product Replacement Utilization Patterns: Data from a Specialty Pharmacy
23. Challenges in Using Real-World Clinical Practice Records for Retrospective Validation of Clinical Trial Data: Lessons Learned
24. Sexual and Reproductive Issues for Men With Inflammatory Bowel Disease
25. Corrigendum: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease
26. EGD First in Bi-directional Endoscopy Is Associated with Decreased Medication Use and Time: A Quality Improvement Initiative
27. Increasing the Value of VTE Prophylaxis in Patients Admitted to a Subspecialty Gastroenterology Inpatient Service
28. Clinical Presentation and Risk Factors for Phlegmonous Gastritis: Beware of ‘Suppression and Stasisʼ
29. Predictive Factors Associated with Positive Endoscopic Findings During Evaluation for Iron Deficiency Anemia
30. Mentoring in Gastroenterology
31. Vedolizumab for Moderate to Severely Active Inflammatory Bowel Disease: A Multicenter U.S. Consortium
32. Skin Cancer Screening in Inflammatory Bowel Disease Patients on Chronic Immunosuppressant Therapy: A Quality Improvement Project
33. Clinical Features of Drug-Induced Lupus in Patients With IBD Treated With Anti-TNF-α Therapy
34. Hepatitis B Vaccine in IBD
35. Male Contraception Use During Valganciclovir Treatment for Cytomegalovirus Colitis
36. The Role of Diagnostic Colonoscopy in Evaluating Constipation: An Assessment for Quality Improvement in an Endoscopic Practice
37. Antibiotics and Oral Contraceptive Efficacy in Inflammatory Bowel Disease
38. Long-term Compliance with Mesalamine Therapy in Patients with Quiescent Ulcerative Colitis: Results from a Long-term Phase IV Study of MMX® Mesalamine
39. The Role of Diagnostic Colonoscopy in Constipation: A Quality Improvement Project
40. Intestinal Wall Remodeling on CT Enterography May Not Predict Improved Bone Health
41. TOUCH™ Study Patient Outcomes: Workforce Participation, Productivity and the Impact of Natalizumab
42. Reductions in Rates of Hospitalization and Short-term Health Care Costs in Patients Who Adhered to Adalimumab Maintenance Therapy for Crohnʼs Disease
43. Case of Ulcerative Colitis Treated with Infliximab Complicated by Hepatic Hemangioendothelioma
44. Once Daily Dosing of Delayed-Release Oral Mesalamine (400 mg Tablet) is as Effective as Twice Daily Dosing for Maintenance of Remission of Ulcerative Colitis: Results of the QDIEM Study
45. Should Patients with Severe Reflux Esophagitis Undergo Repeat Endoscopy After 8 to 12 Weeks of Proton Pump Inhibitor (PPI) Therapy to Exclude Underlying Barrettʼs Esophagus (BE)? Preliminary Results from Two Prospective Trials
46. Recurrent Appendicitis Masquerading as Crohnʼs Disease
47. Predictors of 5-ASA Prescription Persistence during the Chronic Phase in Patients with Ulcerative Colitis (UC)
48. Measurement of ASCA, Lactoferrin and Clostridium Difficile in Feces of Patients with IBD
49. METABOLITES TO IMMUNOMODULATORS ARE NOT DECTECTED IN BREAST MILK
50. Corticosteroid Avoidance in Patients with Crohnʼs Disease Who Are Newly Initiated to Therapy with an Anti-TNF Versus Azathioprine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.